PEAK6 Investments’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,811
Closed -$266K 4510
2023
Q2
$245K Sell
20,811
-38,217
-65% -$435K ﹤0.01% 2751
2023
Q1
$679K Buy
59,028
+51,935
+732% +$642K ﹤0.01% 2146
2022
Q4
$88.2K Sell
7,093
-19,450
-73% -$248K ﹤0.01% 3719
2022
Q3
$348K Sell
26,543
-22,519
-46% -$333K ﹤0.01% 3216
2022
Q2
$640K Buy
49,062
+15,149
+45% +$203K ﹤0.01% 3551
2022
Q1
$505K Buy
33,913
+9,921
+41% +$136K ﹤0.01% 3121
2021
Q4
$325K Buy
+23,992
New +$340K ﹤0.01% 3592
2020
Q1
Sell
-5,930
Closed -$109K 4486
2019
Q4
$127K Buy
+5,930
New +$133K ﹤0.01% 2772

Other funds holding SBRA

PEAK6 Investments's SBRA Position: Q3 2023 in Review

PEAK6 Investments sold out of Sabra Healthcare REIT (SBRA) in Q3 2023, closing a stake of 20,811 shares — an estimated $266K sold.

PEAK6 Investments first reported a position in SBRA in Q4 2019 and held it in 8 quarters. The position peaked at $679K in Q1 2023. 329 funds tracked by Wall St. Rank hold SBRA as of Q3 2023.

  • PEAK6 Investments reported no remaining Sabra Healthcare REIT position as of Q3 2023 after selling out during the quarter.
  • PEAK6 Investments sold 20,811 Sabra Healthcare REIT shares in Q3 2023, an estimated $266K.
  • PEAK6 Investments first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 8 quarters.
  • PEAK6 Investments's Sabra Healthcare REIT position peaked at $679K in Q1 2023.
  • 329 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.